Literature DB >> 22049072

Activation of TRPV4 on dural afferents produces headache-related behavior in a preclinical rat model.

Xiaomei Wei1, Rebecca M Edelmayer, Jin Yan, Gregory Dussor.   

Abstract

BACKGROUND: The mechanisms contributing to the pain of migraine are poorly understood although activation of afferent nociceptors in the trigeminovascular system has been proposed as a key event. Prior studies have shown that dural-afferent nociceptors are sensitive to both osmotic and mechanical stimuli. Based on the sensitivity to these stimuli we hypothesized that dural afferents express the osmo/mechano-sensitive channel transient receptor-potential vanilloid 4 (TRPV4).
METHODS: These studies used in vitro patch-clamp electrophysiology of trigeminal neurons retrogradely labeled from the dura to examine the functional expression of TRPV4. Additionally, we used a rat headache model in which facial/hind paw allodynia following dural stimulation is measured to determine whether activation of meningeal TRPV4 produces responses consistent with migraine.
RESULTS: These studies found that 56% and 49% of identified dural afferents generate currents in response to hypotonic solutions and 4α-PDD, respectively. The response to these stimuli indicates that dural afferents express TRPV4. Activation of meningeal TPRV4 using hypotonic solution or 4α-PDD in vivo resulted in both facial and hind paw allodynia that was blocked by the TRPV4 antagonist RN1734.
CONCLUSION: These data indicate that activation of TRPV4 within the meninges produces afferent nociceptive signaling from the head that may contribute to migraine headache.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22049072      PMCID: PMC3543146          DOI: 10.1177/0333102411427600

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  24 in total

1.  Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat.

Authors:  H Kaube; K L Hoskin; P J Goadsby
Journal:  Cephalalgia       Date:  1992-06       Impact factor: 6.292

2.  Changes in transient receptor potential cation channel superfamily V (TRPV) mRNA expression in the mouse inner ear ganglia after kanamycin challenge.

Authors:  Tadashi Kitahara; Ha-Sheng Li; Carey D Balaban
Journal:  Hear Res       Date:  2005-03       Impact factor: 3.208

3.  The prevalence and characteristics of migraine in a population-based cohort: the GEM study.

Authors:  L J Launer; G M Terwindt; M D Ferrari
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

Review 4.  Mast cell involvement in the pathophysiology of migraine headache: A hypothesis.

Authors:  Dan Levy; Rami Burstein; Andrew M Strassman
Journal:  Headache       Date:  2006-06       Impact factor: 5.887

5.  Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.

Authors:  Andrew D Grant; Graeme S Cottrell; Silvia Amadesi; Marcello Trevisani; Paola Nicoletti; Serena Materazzi; Christophe Altier; Nicolas Cenac; Gerald W Zamponi; Francisco Bautista-Cruz; Carlos Barajas Lopez; Elizabeth K Joseph; Jon D Levine; Wolfgang Liedtke; Stephen Vanner; Nathalie Vergnolle; Pierangelo Geppetti; Nigel W Bunnett
Journal:  J Physiol       Date:  2006-11-23       Impact factor: 5.182

6.  Sensitization of meningeal sensory neurons and the origin of headaches.

Authors:  A M Strassman; S A Raymond; R Burstein
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

7.  Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators.

Authors:  Xi-Chun Zhang; Andrew M Strassman; Rami Burstein; Dan Levy
Journal:  J Pharmacol Exp Ther       Date:  2007-05-04       Impact factor: 4.030

8.  Mast cell degranulation activates a pain pathway underlying migraine headache.

Authors:  Dan Levy; Rami Burstein; Vanessa Kainz; Moshe Jakubowski; Andrew M Strassman
Journal:  Pain       Date:  2007-04-24       Impact factor: 6.961

9.  Impaired osmotic sensation in mice lacking TRPV4.

Authors:  Atsuko Mizuno; Naoko Matsumoto; Masashi Imai; Makoto Suzuki
Journal:  Am J Physiol Cell Physiol       Date:  2003-07       Impact factor: 4.249

10.  Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.

Authors:  Hiroyuki Watanabe; Joris Vriens; Jean Prenen; Guy Droogmans; Thomas Voets; Bernd Nilius
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

View more
  23 in total

1.  pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators.

Authors:  Jin Yan; Xiaomei Wei; Christina Bischoff; Rebecca M Edelmayer; Gregory Dussor
Journal:  Headache       Date:  2013-06-28       Impact factor: 5.887

2.  Non-invasive dural stimulation in mice: A novel preclinical model of migraine.

Authors:  Carolina Christina Burgos-Vega; Lilyana D Quigley; Gabriela Trevisan Dos Santos; Flora Yan; Marina Asiedu; Blaine Jacobs; Marina Motina; Nida Safdar; Hayyan Yousuf; Amanda Avona; Theodore John Price; Greg Dussor
Journal:  Cephalalgia       Date:  2018-05-31       Impact factor: 6.292

3.  Regulation of Piezo2 Mechanotransduction by Static Plasma Membrane Tension in Primary Afferent Neurons.

Authors:  Zhanfeng Jia; Ryo Ikeda; Jennifer Ling; Viacheslav Viatchenko-Karpinski; Jianguo G Gu
Journal:  J Biol Chem       Date:  2016-02-29       Impact factor: 5.157

4.  Activation of TRPA1 on dural afferents: a potential mechanism of headache pain.

Authors:  Rebecca M Edelmayer; Larry N Le; Jin Yan; Xiaomei Wei; Romina Nassini; Serena Materazzi; Delia Preti; Giovanni Appendino; Pierangelo Geppetti; David W Dodick; Todd W Vanderah; Frank Porreca; Gregory Dussor
Journal:  Pain       Date:  2012-07-17       Impact factor: 6.961

5.  Cranial dural permeability of inflammatory nociceptive mediators: Potential implications for animal models of migraine.

Authors:  Jun Zhao; Dara Bree; Michael G Harrington; Andrew M Strassman; Dan Levy
Journal:  Cephalalgia       Date:  2016-08-19       Impact factor: 6.292

Review 6.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

7.  The increased distensibility of the wall of cerebral arterial network may play a role in the pathogenic mechanism of migraine headache.

Authors:  S Viola; P Viola; M P Buongarzone; L Fiorelli; P Litterio
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 8.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 9.  Regulation of Pain and Itch by TRP Channels.

Authors:  Carlene Moore; Rupali Gupta; Sven-Eric Jordt; Yong Chen; Wolfgang B Liedtke
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

10.  Temporomandibular joint pain: a critical role for Trpv4 in the trigeminal ganglion.

Authors:  Yong Chen; Susan H Williams; Amy L McNulty; Ji Hee Hong; Suk Hee Lee; Nicole E Rothfusz; Puja K Parekh; Carlene Moore; Robert W Gereau; Andrea B Taylor; Fan Wang; Farshid Guilak; Wolfgang Liedtke
Journal:  Pain       Date:  2013-04-06       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.